Bromfenac 0.09% bioavailability in aqueous humor, prophylactic effect on cystoid macular edema, and clinical signs of ocular inflammation after phacoemulsification in a Mexican population

Arieh R. Mercado-SesmaClaudia Palacio-PastranaLourdes OrtegaFrancisco BustosEduardo ChávezAldo Oregon2026-03-222026-03-22201610.2147/opth.s93530https://doi.org/10.2147/opth.s93530https://andeanlibrary.org/handle/123456789/50751Citaciones: 5Bromfenac 0.09% ophthalmic solution showed similar clinical efficacy to reduce the presentation of CME after phacoemulsification compared to nepafenac 0.01%.enMedicineChemosisOphthalmologyMacular edemaIntraocular pressurePhacoemulsificationEdemaPlaceboUveitisAnesthesiaBromfenac 0.09% bioavailability in aqueous humor, prophylactic effect on cystoid macular edema, and clinical signs of ocular inflammation after phacoemulsification in a Mexican populationarticle